phase iii medalist trial of luspatercept for mds
Published 4 years ago • 923 plays • Length 7:14Download video MP4
Download video MP3
Similar videos
-
3:44
dr shallis on the utility of luspatercept in the element-mds trial in mds
-
6:32
luspatercept reduces transfusion burden in mds-related anemia: medalist results
-
2:14
trial updates for luspatercept in lr-mds: commands, medalist and elements-mds
-
3:54
results of medalist: luspatercept reduces transfusion burden in mds
-
1:12
medalist: os & risk of disease progression in patients with mds treated with luspatercept
-
2:30
medalist: luspatercept and erythropoiesis biomarkers in mds
-
1:31
overall survival of patients following treatment with luspatercept in the medalist trial
-
6:31
results from the medalist trial for patients with anaemia in mds
-
1:37
phase iii independence trial of luspatercept in patients with td myelofibrosis on jaki therapy
-
6:34
alan f. list: the medalist trial
-
1:06
commands trial: luspatercept vs epoetin alfa in lower-risk mds
-
2:52
long-term evaluation of luspatercept in esa-intolerant/refractory lr-mds: medalist follow-up study
-
0:44
dr. patel on the clinical implications of luspatercept approval in mds
-
0:56
luspatercept for mds-associated anemia
-
0:56
the promise of luspatercept for the treatment of lower-risk mds
-
1:00
findings from the commands study and the approval of luspatercept for lower-risk mds
-
2:12
improving the treatment of low-risk mds: luspatercept, treatment sequencing & disease classification
-
4:12
what does data from the phase iii commands trial reveal about luspatercept as a treatment option?
-
1:40
long-term follow-up of luspatercept: response duration and progression to aml